Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Conduit Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
CDT
Nasdaq
8731
https://www.conduitpharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Conduit Pharmaceuticals Inc
Conduit Pharmaceuticals Adds Key Leadership Positions
- Mar 19th, 2024 2:57 pm
Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
- Mar 19th, 2024 11:00 am
Conduit Pharmaceuticals Opens New Laboratory in UK
- Mar 11th, 2024 6:26 pm
Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences Hub
- Mar 11th, 2024 11:00 am
Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Jan 31st, 2024 1:30 pm
Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference
- Nov 2nd, 2023 12:30 pm
Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656
- Oct 11th, 2023 12:30 pm
Conduit Pharma CEO Tapolczay on Biopharma Differentiation, Pipeline
- Oct 6th, 2023 1:29 pm
Presidio Property Trust Announces Closing of Merger of Its Sponsored SPAC Murphy Canyon Acquisition Corp Now Trading as Conduit Pharmaceuticals (Nasdaq: CDT and CDTTW)
- Oct 6th, 2023 12:30 pm
Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination
- Sep 22nd, 2023 1:01 pm
Scroll